EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long‐Term Risk of Incident Type 2 Diabetes Following SARS‐CoV‐2 Infection: A Population‐Based Study in British Columbia, Canada

Héctor Alexander Velásquez García iD, Stanley Wong, Dahn Jeong, Zaeema Naveed, Bushra Mahmood, Geoffrey McKee, Naveed Zafar Janjua iD

Diabetes/Metabolism Research and Reviews · 2026

DOI: 10.1002/dmrr.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2026. Verfasst von Héctor Alexander Velásquez García und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of British Columbia Centre for Disease Control (UBC CDC), Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Michael Smith Health Research BC, Public Health Agency of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the long‐term risk of incident type 2 diabetes mellitus (T2DM) following SARS‐CoV‐2 infection in a large population‐based cohort. Materials and Methods We conducted a retrospective cohort study of all British Columbia residents aged ≥ 18 years tested for SARS‐CoV‐2 by reverse transcription polymerase chain reaction (RT‐PCR) between 1 January 2020 and 31 January 2024. Individuals with pre‐existing diabetes or residing in long‐term care were excluded. Incident T2DM, identified more than 30 days after testing, was ascertained using a validated administrative algorithm. Inverse probability‐weighted cause‐specific hazard models estimated adjusted hazard ratios (HRs) for incident diabetes, accounting for death as a competing risk. Subgroup analyses examined associations by sex, age, vaccination status, COVID‐19 severity, and follow‐up duration.

Results

Among 2,044,421 individuals (296,390 SARS‐CoV‐2‐positive; 1,748,031 negative), 47,704 (2.33%) incident T2DM cases were identified over a median follow‐up of 874 days. Compared with the SARS‐CoV‐2‐negative group, the risk of diabetes was higher among infected individuals (HR 1.18; 95% CI: 1.15–1.22; p < 0.0001), rising progressively with illness severity—from ambulatory to hospitalised and intensive‐care cases. No evidence of association was found among the vaccinated subgroups. The excess risk persisted for up to 3 years before waning thereafter.

Conclusions

SARS‐CoV‐2 infection was associated with an increased risk of incident T2DM that persisted for up to 3 years, particularly among unvaccinated and severely ill individuals. These findings highlight the importance of post‐infection metabolic surveillance and the potential protective role of vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2COVID-19SARS-CoV-2HumansBritish ColumbiaFemaleMaleRetrospective StudiesMiddle AgedAgedIncidenceAdultRisk FactorsAged, 80 and overFollow-Up Studies

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2administrative datapopulation‐based longitudinal cohortsurvival analysistype 2 diabetes mellitus

Autor:innen und Institutionen

  • University of British Columbia Centre for Disease Control (UBC CDC), Vancouver, British Columbia, Canada.
  • British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Centre for Health Evaluation and Outcome Sciences (CHÉOS), St. Paul's Hospital, Vancouver, British Columbia, Canada.

ORCID-Profile: Héctor Alexander Velásquez García, Naveed Zafar Janjua

Förderung

  • CIHR
  • Michael Smith Health Research BC
  • Public Health Agency of Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Velásquez García, H. A., Wong, S., Jeong, D., Naveed, Z., Mahmood, B., McKee, G., & Janjua, N. Z. (2026). Long‐Term Risk of Incident Type 2 Diabetes Following SARS‐CoV‐2 Infection: A Population‐Based Study in British Columbia, Canada. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70136

Vancouver

Velásquez García HA, Wong S, Jeong D, Naveed Z, Mahmood B, McKee G, et al. Long‐Term Risk of Incident Type 2 Diabetes Following SARS‐CoV‐2 Infection: A Population‐Based Study in British Columbia, Canada. Diabetes/Metabolism Research and Reviews. 2026. doi:10.1002/dmrr.70136

BibTeX
@article{VelsquezGarca2026,
  author = {Velásquez García, Héctor Alexander and Wong, Stanley and Jeong, Dahn and Naveed, Zaeema and Mahmood, Bushra and McKee, Geoffrey and Janjua, Naveed Zafar},
  title = {Long‐Term Risk of Incident Type 2 Diabetes Following SARS‐CoV‐2 Infection: A Population‐Based Study in British Columbia, Canada},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  doi = {10.1002/dmrr.70136}
}
Kostenlos starten →